68Ga-FAPI

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug Name68Ga-FAPI
Drug Alias Name68Ga-FAPI
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Gallium > 68Ga
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsHeart Failure, DiastolicMyositisLung Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College HospitalThe First Affiliated Hospital Of Xiamen UniversityNational Cancer Institute +[4] 
Inactive CompaniesStanford University +[2] 
Active IndicationsHeart Failure, DiastolicMyositisLung Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A